Angelyn Lowe

With more than 25 years of experience, Angelyn is an accomplished biopharma executive, with a background in strategic planning, executive leadership and coaching, corporate development, commercial planning, marketing communications, investor relations and public affairs.

Prior to joining Aspen, Angelyn served as Vice President of Corporate Affairs for rare diseases company Akcea Therapeutics, acquired by Ionis Pharmaceuticals in 2020. Before Akcea, she was head of corporate communications and marketing operations at legacy biotech Organogenesis, a publicly traded cell therapy and biomaterials portfolio/platform company. Earlier in her career, Angelyn held executive and leadership roles in both corporate and consulting environments where she served as a strategic advisor in key sectors including biotech and pharmaceuticals, transit and urban development, and travel, gaming and sports entertainment. Angelyn received her undergraduate degree in communications from Point Loma Nazarene University.